Home » Headlines » Currently Reading:

Morning Headlines 8/22/18

August 21, 2018 Headlines No Comments

Paul Singer, Doomsday Investor

A New Yorker article describes the hostile shareholder attack launched last year on Athenahealth by activist investor Paul Singer’s Elliott Management, noting how the firm often uses questionably ethical tactics to pressure recalcitrant CEOs of targeted companies.

Alphabet-backed One Medical is in talks to raise more than $200 million 

CNBC reports that primary care group One Medical is discussing a possible $200 million fund raise from a private equity firm that will also buy $100 million of existing shares.

NCPDP Takes Ownership of NIST ePrescribing Testing Tool

NCPDP takes ownership of NIST’s ERx Validation Suite, an ONC-approved e-prescribing testing tool.

Recondo Acquires Reseller Client Base from Optum

Recondo takes over the contracts of customers who had purchased a subset of its EmpoweredPatientAccess patient access solutions from The Advisory Board Company via a reseller agreement.

How Facebook — yes, Facebook — might make MRIs faster

Facebook’s AI team works with New York University’s medical school to develop an algorithm that could speed up the MRI process.

View/Print Text Only View/Print Text Only


HIStalk Featured Sponsors

     







Subscribe to Updates

Search


Loading

Text Ads


Report News and Rumors

No title

Anonymous online form
E-mail
Rumor line: 801.HIT.NEWS

Tweets

Archives

Founding Sponsors


 

Platinum Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gold Sponsors


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reader Comments

  • Justa Trench Rat: Nice to see Cerner continuing with their new campus. I am sure our implementation of their highly questionable revenue ...
  • FRANK POGGIO: Shows to go ya...answering black and white Jeopardy questions is a far cry from the massive grey area of medicine/pharma...
  • Number Cruncher: You are right AC. The cost is seriously underestimated here. Just looking at the numbers - $1 B for 5 years = $200 M ...
  • Abraham Van Helsing: Re Theranos. Will be interesting to follow the saga. As I and others had noted going back 2+ years, something was obvi...
  • Prof. Moriarty: Re: Watson pull out. I've not been directly involved with this product, but from its beginning I have always seen Watso...
  • mih: Of course they can, and for much much cheaper. But why would they do it? Existing arrangement works for everyone in the ...
  • Andrew M. Harrison: Thanks for (actually) reading our paper. I enjoyed the story of your friend, as well as the translation of numbers to em...
  • Mike: I would love to see this type of discussion around Blockchain. It is being hyped heavily currently. Yet, I wonder how we...
  • Brian Too: Just slightly off-topic, but I recently heard an interesting downtime rule-of-thumb: Every hour of downtime requires 2 ...
  • James E Thompson: AI in particular isn't disruptive until it can offer an effective alternative against which a go/no-go decision makes se...

RSS Industry Events

  • An error has occurred, which probably means the feed is down. Try again later.

Sponsor Quick Links